2:00 National Cancer Institute’s Biospecimen Research Network
Helen M. Moore, Ph.D., Biospecimen Research Network Program Manager, Office
of Biorepositories and Biospecimen Research, Office of the Director National
Cancer Institute
2:30 Isolation of DNA and RNA from PPFE Tissues Tom Gilbert, Ph.D., Associate Professor, Lektor, Department of Biology,
University of Copenhagen A diverse number of protocols have been published with
regards to the recovery of nucleic acids from fixed tissues. However, in light
of the wide range of down-stream genetic applications that may be subsequently
be applied to the extracts, a cross comparison of the methods’ suitabilities
is desirable. In this talk I summarize recent findings as to how to optimize
the quality of nucleic acids from such materials.
3:00 Using
a Globally Collected Repository of Human DNA Samples With Highly
Annotated Data to Create Data Dense Case Control Studies on a Plate
Kevin Krenitsky, M.D., CEO, BioServe The
application of richly annotated DNA samples has the potential to be a
revolutionary force for how case-control studies are conducted. Matched DNA
case-control studies in ready made 96 and 360 well plate formats, across a
wide range of diseases, presents a powerful new approach for researchers to
efficiently validate case-control studies that lead to better diagnostic and
therapeutic targets.
Sponsored by
3:30 Networking Refreshment Break, Poster and Exhibit Viewing
Amplification
4:15 Molecular Profiling of Circulating Tumor Cells
Mark Connelly, Ph.D., Vice President, Department of Reagent Development,
Immunicon
New data and developments on:
FDA approvals of CTC analysis in new cancer
FISH analysis on isolating CTCs, looking for gene
amplifications, Chromosome counts and rearrangements
4:45 Solution Showcase (Sponsorship Available)
5:00 Amplification of Microarray Hybridization Targets with a Fully
Automated System
Mingjie Zhou, Ph.D., R&D Group, Rosetta Inpharmatics LLC, a wholly owned
subsidiary Merck & Co. Inc.
5:30 RNA Next Generation Isothermal RNA and DNA Amplification
Technologies
Huimin Kong, Ph.D., President & CEO, Biohelix Inc. Two isothermal platforms are being presented:
RT-HDA for RNA amplification
a novel, primase-based whole genome amplification system which is useful
for sample-prep and CGH
